Apimeds Pharmaceuticals US (APUS) News
NYSE: APUSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
APUS news summary
We found 1 recent headline mentioning Apimeds Pharmaceuticals US (APUS): 1 in the past week and 1 in the past 30 days, most often from GlobeNewswire. APUS is making an outsized move today, down 8.89% at $5.02, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "MindWave Innovations Signs 3 Client Network Agreements in 10 Days, Extending MindChain into Climate Finance, Sports Media and Insurance; Apimeds Pharmaceuticals US Provides Required NYSE American Disclosure", was published by GlobeNewswire on Oct 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology